210 related articles for article (PubMed ID: 25987535)
1. Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma.
Hoffman-Censits J; Wong YN
Clin Genitourin Cancer; 2015 Aug; 13(4):302-308. PubMed ID: 25987535
[TBL] [Abstract][Full Text] [Related]
2. Systemic chemotherapy for urothelial cancer.
Sonpavde G; Hutson TE; Berry WR
Clin Genitourin Cancer; 2006 Jun; 5(1):34-42. PubMed ID: 16859577
[TBL] [Abstract][Full Text] [Related]
3. Second-line systemic therapy for metastatic urothelial carcinoma of the bladder.
Ortmann CA; Mazhar D
Future Oncol; 2013 Nov; 9(11):1637-51. PubMed ID: 24156324
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for transitional cell carcinoma of the bladder: paradigms for the design of clinical trials.
Boyar M; Petrylak DP
Curr Oncol Rep; 2005 May; 7(3):207-14. PubMed ID: 15847712
[TBL] [Abstract][Full Text] [Related]
5. Targeted agents in second-line bladder cancer therapy.
Gerullis H; Otto T; Ecke TH
Anticancer Drugs; 2012 Nov; 23(10):1003-15. PubMed ID: 22914698
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy for urothelial cancer of the bladder--update 2012].
Niegisch G; Lorch A; Albers P
Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for urothelial (bladder) cancer.
Cumberbatch K; He T; Thorogood Z; Gartrell BA
Expert Opin Emerg Drugs; 2017 Jun; 22(2):149-164. PubMed ID: 28556678
[TBL] [Abstract][Full Text] [Related]
9. [Current developments in the medical treatment of advanced urothelial carcinoma of the bladder].
Schmid SC; Gschwend JE; Retz M;
Aktuelle Urol; 2014 Jan; 45(1):55-63; quiz 64-5. PubMed ID: 24500963
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
McCaffrey JA; Herr HW
Surg Oncol Clin N Am; 1997 Oct; 6(4):667-81. PubMed ID: 9309087
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology and targeted therapies for urothelial carcinoma.
Seront E; Machiels JP
Cancer Treat Rev; 2015 Apr; 41(4):341-53. PubMed ID: 25828962
[TBL] [Abstract][Full Text] [Related]
12. [Systemic chemotherapy of urothelial cancer].
Wolff JM; Jakse G
Urologe A; 1992 May; 31(3):W19-24. PubMed ID: 1615589
[No Abstract] [Full Text] [Related]
13. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
Walther PJ
Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
[No Abstract] [Full Text] [Related]
14. Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma.
Tabayoyong W; Li R; Gao J; Kamat A
Urol Clin North Am; 2018 May; 45(2):155-167. PubMed ID: 29650132
[TBL] [Abstract][Full Text] [Related]
15. Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises.
Aragon-Ching JB; Trump DL
Future Oncol; 2016 Sep; 12(17):2049-58. PubMed ID: 27306417
[TBL] [Abstract][Full Text] [Related]
16. [New approval: Avelumab - maintenance therapy for advanced or metastatic urothelial carcinoma].
Le Brun IC; Benderra MA
Bull Cancer; 2021 Sep; 108(9):784-786. PubMed ID: 34332742
[No Abstract] [Full Text] [Related]
17. Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.
Pectasides D; Pectasides M; Nikolaou M
Eur Urol; 2005 Jul; 48(1):60-7; discussion 67-8. PubMed ID: 15967253
[TBL] [Abstract][Full Text] [Related]
18. [Systemic chemotherapy for bladder cancer: news in 2009].
Retz M; Gschwend JE; Lehmann J
Urologe A; 2009 Jun; 48(6):655-62. PubMed ID: 19557469
[TBL] [Abstract][Full Text] [Related]
19. Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer.
Henon C; Huillard O; Preta LH; Blanchet B; Goldwasser F; Alexandre J
Clin Genitourin Cancer; 2017 Jun; 15(3):e493-e495. PubMed ID: 28233698
[No Abstract] [Full Text] [Related]
20. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma.
Gin GE; Ruel NH; Kardos SV; Sfakianos JP; Uchio E; Lau CS; Yuh BE
Urol Oncol; 2017 May; 35(5):192-200. PubMed ID: 28041996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
